Atlas Private Wealth Advisors Sells 200 Shares of MetLife, Inc. (NYSE:MET)

Atlas Private Wealth Advisors decreased its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 6.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,136 shares of the financial services provider’s stock after selling 200 shares during the period. Atlas Private Wealth Advisors’ holdings in MetLife were worth $257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. Exchange Traded Concepts LLC grew its position in shares of MetLife by 7.4% during the 4th quarter. Exchange Traded Concepts LLC now owns 3,416 shares of the financial services provider’s stock valued at $280,000 after acquiring an additional 235 shares during the period. CX Institutional grew its position in shares of MetLife by 15.9% during the 4th quarter. CX Institutional now owns 68,005 shares of the financial services provider’s stock valued at $5,568,000 after acquiring an additional 9,337 shares during the period. Impact Partnership Wealth LLC grew its position in shares of MetLife by 67.5% during the 4th quarter. Impact Partnership Wealth LLC now owns 17,168 shares of the financial services provider’s stock valued at $1,406,000 after acquiring an additional 6,919 shares during the period. RFG Advisory LLC grew its position in shares of MetLife by 49.7% during the 4th quarter. RFG Advisory LLC now owns 9,881 shares of the financial services provider’s stock valued at $809,000 after acquiring an additional 3,282 shares during the period. Finally, McGlone Suttner Wealth Management Inc. grew its position in shares of MetLife by 4.7% during the 4th quarter. McGlone Suttner Wealth Management Inc. now owns 16,869 shares of the financial services provider’s stock valued at $1,381,000 after acquiring an additional 750 shares during the period. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Down 0.9 %

Shares of MET stock opened at $85.96 on Friday. The stock has a market cap of $59.52 billion, a P/E ratio of 17.33, a PEG ratio of 0.65 and a beta of 1.07. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company’s fifty day simple moving average is $83.76 and its two-hundred day simple moving average is $79.87.

MetLife Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is 43.95%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. TD Cowen boosted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Wells Fargo & Company dropped their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a report on Tuesday, January 14th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. BMO Capital Markets initiated coverage on shares of MetLife in a report on Thursday. They issued a “market perform” rating and a $97.00 target price for the company. Finally, Jefferies Financial Group upped their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus price target of $90.46.

Read Our Latest Stock Analysis on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.